- Home
- Publications
- Publication Search
- Publication Details
Title
Psoriasis: A STAT3-Centric View
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 1, Pages 171
Publisher
MDPI AG
Online
2018-01-09
DOI
10.3390/ijms19010171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of the Itch Severity Item as a Measurement Tool for Pruritus in Patients with Psoriasis: Results from a Phase 3 Tofacitinib Program
- (2018) S Ständer et al. ACTA DERMATO-VENEREOLOGICA
- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis
- (2017) Zarif K. Jabbar-Lopez et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Comment on “Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis”
- (2017) Kristian Reich et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis and comorbid diseases
- (2017) Junko Takeshita et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- JAK Inhibitors Taking on Psoriatic Arthritis
- (2017) Robert A. Colbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
- (2017) Philip Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
- (2017) Dafna Gladman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial
- (2017) Vibeke Strand et al. ARTHRITIS CARE & RESEARCH
- Janus kinase inhibitors for rheumatoid arthritis
- (2016) Kunihiro Yamaoka CURRENT OPINION IN CHEMICAL BIOLOGY
- Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3
- (2016) Luting Yang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a
- (2016) Ka Lun Cheung et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Selective Destruction of Interleukin 23–Induced Expansion of a Major Antigen–Specific γδ T-Cell Subset in Patients With Tuberculosis
- (2016) Hongbo Shen et al. JOURNAL OF INFECTIOUS DISEASES
- Biological and pathological activities of interleukin-22
- (2016) Mirna Perusina Lanfranca et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis
- (2016) Steven R. Feldman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- (2016) Vito Di Lernia et al. Drug Design Development and Therapy
- JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
- (2016) Ana Karina Alves de Medeiros et al. PLoS One
- Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
- (2015) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Cytokines in psoriasis
- (2015) Jaymie Baliwag et al. CYTOKINE
- Insights into IL-23 biology: From structure to function
- (2015) Doreen M. Floss et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Dermal IL-17-producing γδ T cells establish long-lived memory in the skin
- (2015) Tom Hartwig et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
- (2015) Michele W L Teng et al. NATURE MEDICINE
- Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+T cells
- (2015) Chi-Keung Wan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation induces dermal Vγ4+γδT17 memory-like cells that travel to distant skin and accelerate secondary IL-17–driven responses
- (2015) Francisco Ramírez-Valle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era
- (2014) William R Swindell et al. BMC Medical Genomics
- Constitutive STAT3 activation in epidermal keratinocytes enhances cell clonogenicity and favours spontaneous immortalization by opposing differentiation and senescence checkpoints
- (2014) Valeria Orecchia et al. EXPERIMENTAL DERMATOLOGY
- IL-7 Receptor Blockade Inhibits IL-17-Producing γδ Cells and Suppresses Melanoma Development
- (2014) Jun Li et al. INFLAMMATION
- IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
- (2014) Ellen Witte et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
- (2014) J. Wollenhaupt et al. JOURNAL OF RHEUMATOLOGY
- Psoriasis prevalence among adults in the United States
- (2014) Tara D. Rachakonda et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
- (2014) Sarah E Flanagan et al. NATURE GENETICS
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy
- (2013) Annalisa Camporeale et al. EMBO Molecular Medicine
- Tumor Necrosis Factor Receptor Signaling in Keratinocytes Triggers Interleukin-24-Dependent Psoriasis-like Skin Inflammation in Mice
- (2013) Snehlata Kumari et al. IMMUNITY
- Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells
- (2013) Elissa K. Deenick et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Keratin 17: A Critical Player in the Pathogenesis of Psoriasis
- (2013) Liang Jin et al. MEDICINAL RESEARCH REVIEWS
- The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
- (2013) Michelle A. Lowes et al. TRENDS IN IMMUNOLOGY
- Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci
- (2012) David Ellinghaus et al. AMERICAN JOURNAL OF HUMAN GENETICS
- IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
- (2012) Annalisa Camporeale Frontiers in Bioscience-Landmark
- The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells
- (2012) Anne Brüstle et al. JOURNAL OF CLINICAL INVESTIGATION
- Keratin 17 as a therapeutic target for the treatment of psoriasis
- (2012) Meng Fu et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
- (2012) Naresh Punwani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
- (2012) Lam C Tsoi et al. NATURE GENETICS
- The Pro-Inflammatory Cytokine IL-22 Up-Regulates Keratin 17 Expression in Keratinocytes via STAT3 and ERK1/2
- (2012) Wei Zhang et al. PLoS One
- STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter
- (2011) Constance Zugowski et al. BIOLOGICAL CHEMISTRY
- Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease
- (2011) Sara Bogaert et al. BMC IMMUNOLOGY
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Distinct Roles of IL-23 and IL-17 in the Development of Psoriasis-Like Lesions in a Mouse Model
- (2011) Kimiko Nakajima et al. JOURNAL OF IMMUNOLOGY
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- IL-17A Upregulates Keratin 17 Expression in Keratinocytes through STAT1- and STAT3-Dependent Mechanisms
- (2011) Xiaowei Shi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
- (2011) Yijun Carrier et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
- (2011) Xiang-Ping Yang et al. NATURE IMMUNOLOGY
- STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation
- (2010) Rosanna Sestito et al. FASEB JOURNAL
- Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
- (2010) Lydia Durant et al. IMMUNITY
- Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis—A possible target for novel therapies?
- (2010) Miriam Canavese et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor
- (2010) Ken Miyoshi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
- (2010) Amy Strange et al. NATURE GENETICS
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
- (2009) Lisa C. Zaba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- (2009) Dipyaman Ganguly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells
- (2009) W. A. Goodman et al. JOURNAL OF IMMUNOLOGY
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not
- (2009) Kerstin Wolk et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
- (2009) Sara Trifari et al. NATURE IMMUNOLOGY
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
- (2009) Thomas Duhen et al. NATURE IMMUNOLOGY
- Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
- (2009) Roberta Caruso et al. NATURE MEDICINE
- Genome-wide discovery of functional transcription factor binding sites by comparative genomics: The case of Stat3
- (2009) F. Vallania et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Psoriasis – as an autoimmune disease caused by molecular mimicry
- (2009) Helgi Valdimarsson et al. TRENDS IN IMMUNOLOGY
- Deficiency of Th17 cells in hyper IgE syndrome due to mutations inSTAT3
- (2008) Cindy S. Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells
- (2008) Lisa C. Zaba et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
- (2008) Joshua D. Milner et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now